Catalonia_edited.png

ITH5 -Emilia Romagna

Regional website


Innovation Performance Group (2021) : Strong

Total population (2019): 4,459,477

Population per km² (2019): 202

Proportion population older 65 year %: 23,95%


Background


The region has a focus on the emerging fields of regenerative and restorative medicine, as well as pharmaceutical and omics sciences and inclusive services and usable technologies for healthy living and active aging.


Emilia-Romagna  is involved in a number of major initiatives in the field of personalised medicine including Hologene, Custom Implants, Italian Infrastructure for Regenerative Medicine, SUPER  HPC and Big Data and Italian Biobanks network.


Is the region looking for international/European/interregional collaboration opportunities? Yes - Identification of standard protocols to collect data and support on how to overcome the barriers about privacy regulation.


Regional Strategy for Research and Innovation for Smart Specialisation (RIS3)


Major initiatives

 

  1. Hologene 7

  2. Hologene 7 2.0

  3. Custom Implants

  4. IRMI - Italian Infrastructure for Regenerative Medicine

  5. S3P4PM

  6. Medtch4Europe

  7. Reg4PerMed

  8. SUPER HPC and Big Data

  9. BBMRI.it Italian Biobanks network 

  10. Collaboration with Piedmont Region

  11. IZSLER Biobanking of Veterinary Resources (BVR)

  12. BIOGEN: Diagnostic and research genetic Biobank 

  13. ROI: Osteogenesis Imperfecta Registry

  14. BIOGEN - Genetic Biobank 

  15. Italian registry of skeletal dysplasia 

  16. Biorepository of tissue and blood samples, lymphocytes and DNA from patients affected by solitary/multiple osteochondroma and peripheral chondrosarcoma 

  17. Biological Resource Center IRST

  18. Brisighella Heart Study Biobank 

  19. LTTA Biobank (Laboratory for Advanced Therapy Technologies) 

  20. Genetic Biobank 

  21. Tumor Skeletal Tumor Biobank 

  22. REM: Multiple Osteochondromas Registry


Digital Innovation Hubs:


 

Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?


  1. BBMRI  EUS3 Platform - Personalized Medicine

  2. H2020 - SMEINST - Oncosmart - ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics

  3. H2020- SMEINST- BIOFOSTE - Clinical validation of a BIOmarker panel For OSTEoarthritis diagnosis: BIOFOSTE

  4. H2020 - SC1- ADIPOA2 - Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis

Membership status


  • Member Euregha

  • Adriatic-Ionian MacroRegion

  • InnoStars Region

  • S3MedTech region

  • S3P4PM region

  • Regions4PM region

  • Central Europe

  • 1M+Genome initiative - country level member

  • European Regions Research & Innovation Network (ERRIN)

  • Vanguard Initiative

  • S3ClusSport member

Image attribution - By TUBS - Own workThis SVG map includes elements that have been taken or adapted from this map:  Italy location map.svg (by NordNordWest)., CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=14512796